Scientists restore memory by blocking a single Alzheimer’s protein
ScienceDaily • • science
Key Points:
- Researchers have identified that blocking the protein PTP1B can improve learning and memory in a mouse model of Alzheimer's disease by enhancing the function of microglia, the brain's immune cells responsible for clearing amyloid-β (Aβ) plaques.
- PTP1B interacts with spleen tyrosine kinase (SYK), which regulates microglial activity; inhibition of PTP1B helps restore microglial efficiency in clearing Aβ deposits that contribute to Alzheimer's progression.
- Given that PTP1B is also a target for metabolic disorders like obesity and type 2 diabetes—both risk factors for Alzheimer's—targeting this protein could address multiple aspects of the disease.
- Current Alzheimer's treatments mainly focus on reducing Aβ buildup but have limited effectiveness; combining PTP1B inhibitors with existing drugs might enhance therapeutic outcomes by targeting additional disease mechanisms.
- The Tonks lab is collaborating with DepYmed, Inc. to develop PTP1B inhibitors for Alzheimer's and other conditions, aiming to slow disease progression and improve patients' quality of life through multi-faceted treatment strategies.
